IRIS
SAVINI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.442
EU - Europa 2.567
AS - Asia 1.321
SA - Sud America 166
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 7
Totale 7.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.362
RU - Federazione Russa 545
CN - Cina 517
GB - Regno Unito 508
SG - Singapore 396
IE - Irlanda 357
SE - Svezia 224
DE - Germania 202
IT - Italia 202
UA - Ucraina 198
FR - Francia 148
BR - Brasile 131
VN - Vietnam 105
HK - Hong Kong 92
FI - Finlandia 66
KR - Corea 60
CA - Canada 54
IN - India 43
ZA - Sudafrica 41
ES - Italia 32
TR - Turchia 25
CZ - Repubblica Ceca 22
PL - Polonia 16
BD - Bangladesh 11
BE - Belgio 11
MX - Messico 11
AR - Argentina 10
JP - Giappone 9
CO - Colombia 8
IR - Iran 8
IQ - Iraq 7
NG - Nigeria 7
VE - Venezuela 7
UZ - Uzbekistan 6
ID - Indonesia 5
NL - Olanda 5
CL - Cile 4
CR - Costa Rica 4
KE - Kenya 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CH - Svizzera 1
EC - Ecuador 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
NI - Nicaragua 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.574
Salva come PNG Salva come JPEG
Città #
Southend 419
Dublin 356
Ashburn 316
Dallas 299
Fairfield 274
Chandler 233
Singapore 220
San Jose 199
Jacksonville 154
Santa Clara 148
Woodbridge 139
Beijing 129
Moscow 119
Wilmington 105
Seattle 103
Houston 93
Ann Arbor 92
Hong Kong 90
Cambridge 88
Milan 84
Hefei 83
Los Angeles 68
Seoul 60
Nanjing 59
Princeton 57
New York 53
Council Bluffs 51
The Dalles 40
Johannesburg 38
Munich 37
Ho Chi Minh City 36
Menlo Park 34
Boardman 30
Rome 28
Helsinki 25
Lauterbourg 24
London 24
Shanghai 24
Siena 24
San Mateo 21
Hanoi 20
Brno 19
Fremont 19
Málaga 19
Ottawa 19
Shenyang 17
Buffalo 14
Chicago 14
Izmir 14
Nanchang 14
Washington 14
San Diego 13
Dearborn 12
Düsseldorf 12
Warsaw 12
Bengaluru 11
Brussels 11
Mumbai 11
Orem 11
São Paulo 11
Brooklyn 10
Hebei 10
Jiaxing 10
Kunming 10
Tianjin 10
Turku 10
Frankfurt am Main 9
Manchester 9
Montreal 9
Toronto 9
Atlanta 8
Changsha 8
Lancaster 8
Tokyo 8
Abuja 7
Auburn Hills 7
Jinan 7
Taizhou 7
Chennai 6
Da Nang 6
Figino 6
Guangzhou 6
Hangzhou 6
Newark 6
Paris 6
Baghdad 5
Boston 5
Cincinnati 5
Denver 5
Haiphong 5
Memphis 5
Mexico City 5
Naples 5
Phoenix 5
Redwood City 5
Roubaix 5
San Francisco 5
Tashkent 5
Turin 5
Amsterdam 4
Totale 5.035
Salva come PNG Salva come JPEG
Nome #
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 299
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents 294
Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complex 292
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents 288
Chelating agents as potential antitumorals. 2-quinolylhydrazones and bis-2-quinolylhydrazones. I 276
Development of Antitubercular Compounds Based on a 4-Quinolylhydrazone Scaffold. Further Structure-activity Relationship Studies 273
Microwave-assisted synthesis of 4-quinolylhydrazines followed by nickel boride reduction: a convenient approach to 4-aminoquinolines and derivatives 273
New 1-[quinolyl(4)]-1,2,3-triazoles: synthesis and evaluation of antiinflammatory and analgesic properties. II 265
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663 262
ANTIMALARIAL AGENTS HAVING POLYAROMATIC STRUCTURE 260
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 256
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones 256
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore 254
Pyrazolo[4,3-c]quinolines. Synthesis and specific inhibition of benzodiazepine receptor binding (Note I) 253
Malaria chemotherapy: recent advances in drug development 252
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors 249
Chelating agents as potential antitumorals: alfa-(N)-heterocyclic hydrazones and bis-alfa-(N)-heterocyclic hydrazones 239
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 239
Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, Biological and Structure-Activity Relationship Studies 229
Application of near infrared reflectance spectroscopy (NIRS) to several antibiotic compounds 226
Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils 225
Application of NIRS to the control of pharmaceuticals identification and assay of several primary materials 222
Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase 222
New quinoline derivatives: synthesis and evaluation for antiinflammatory and analgesic properties - Note I 219
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors 219
Pyrazolo[4,3-c]quinolines. Synthesis and specific inhibition of benzodiazepine receptor binding. Note II 216
New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity 211
Application of Near-Infrared Reflectance Analysis (NIRA) to the integrated control of antibiotics tablet production 208
Rational design of the first difluorostatone-based PfSUB1 inhibitors 198
Thin layer chromatography in pharmaceutical quality control. Assay of inosiplex in different pharmaceutical forms 180
Tridentate N-N-N chelating systems as potential antitumor agents [Sistemi chelanti tridentati N*-N*-N* quali potenziali agenti antitumorali] 105
On the isomerism/tautomerism of hydrazones. Crystal structures, study in solution and theoretical calculation of new series of α-N-heterocyclic hydrazones 98
null 39
Synthesis and antitubercular evaluation of 4-quinolylhydrazones 2
High affinity central benzodiazepine receptor ligands. Part 3 : insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo [4,3-c]quinolin-3-ones 1
Totale 7.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022283 0 0 0 54 17 4 22 14 14 45 31 82
2022/2023731 38 81 87 111 74 134 12 68 72 24 22 8
2023/2024559 19 14 57 25 25 177 193 3 2 9 1 34
2024/2025960 27 46 138 30 137 37 8 45 108 22 86 276
2025/20262.281 175 289 276 298 478 81 272 51 50 101 40 170
2026/2027344 75 69 194 6 0 0 0 0 0 0 0 0
Totale 7.600